Show Summary Details
Page of

Modern medical management of TIA and stroke 

Modern medical management of TIA and stroke
Modern medical management of TIA and stroke

Victoria J. Haunton

and Thompson G. Robinson

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 July 2020

The World Health Organization defines stroke as ‘a clinical syndrome consisting of rapidly developing clinical signs of focal (at times global) disturbance of cerebral function lasting greater than 24 hours (or leading to death) with no apparent cause other than that of vascular origin’. Transient ischaemic attack has recently been redefined as ‘a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischaemia, without evidence of acute infarction’. Each year, approximately 150,000 people in the UK will have a first or recurrent stroke and 70,000 will have a transient ischaemic attack. Key to effective management of these conditions are robust primary and secondary prevention, better recognition of people at highest risk, urgent specialist stroke care with timely, evidence-based treatments, and dedicated neurorehabilitation.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.